GRFSGrifols, S.A.
Is it safe?
Nothing alarming, nothing pristine: comfortable debt (AA) and typical volatility.
Rock-solid balance sheet, low leverage. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -78% · now 26% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can GRFS take a bad year?
Grifols, S.A. carries $1.67B of net debt at 1.02× EBITDA: a load its earnings can carry.
Net debt · as at FY2024 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 1.02×
Net debt / EBITDA · 3.08× a year ago · the load is coming down
- Interest cover
- 1.67×
Interest cover · operating profit barely covers the interest bill
- Annualised volatility
- 38%
Annualised volatility · roughly twice as jumpy as the market
Details›
- Total debtFY2024
- $2.66B
- Cash and short-term investments
- $985M
- Net debt
- $1.67B
- EBITDA, trailing twelve months
- $1.63B
- Operating profit, trailing twelve months
- $1.19B
- Debt / equity
- 0.45×
- Total debt / EBITDA
- 1.63×
- Annualised volatilitytwo years of daily moves
- 38%
- Worst drawdown on file
- −78%
- Below its 52-week high
- 26%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers, General
Ranks #6 of 7 by RyuScore